These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

257 related items for PubMed ID: 12234290

  • 1. Reduced p21, p27 and vitamin D receptor in the nodular hyperplasia in patients with advanced secondary hyperparathyroidism.
    Tokumoto M, Tsuruya K, Fukuda K, Kanai H, Kuroki S, Hirakata H.
    Kidney Int; 2002 Oct; 62(4):1196-207. PubMed ID: 12234290
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Reduced p18INK4c, p21CIP1/WAF1 and p27KIP1 mRNA levels in tumours of primary and secondary hyperparathyroidism.
    Buchwald PC, Akerström G, Westin G.
    Clin Endocrinol (Oxf); 2004 Mar; 60(3):389-93. PubMed ID: 15009006
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Clinical features and hyperplastic patterns of parathyroid glands in hemodialysis patients with advanced secondary hyperparathyroidism refractory to maxacalcitol treatment and required parathyroidectomy.
    Tominaga Y, Matsuoka S, Sato T, Uno N, Goto N, Katayama A, Haba T, Kazuharu Uchida (Yagoto PTx Forum).
    Ther Apher Dial; 2007 Aug; 11(4):266-73. PubMed ID: 17661832
    [Abstract] [Full Text] [Related]

  • 7. Expression of PRAD1/cyclin D1, retinoblastoma gene products, and Ki67 in parathyroid hyperplasia caused by chronic renal failure versus primary adenoma.
    Tominaga Y, Tsuzuki T, Uchida K, Haba T, Otsuka S, Ichimori T, Yamada K, Numano M, Tanaka Y, Takagi H.
    Kidney Int; 1999 Apr; 55(4):1375-83. PubMed ID: 10201002
    [Abstract] [Full Text] [Related]

  • 8. Vitamin D receptor and PCNA expression in severe parathyroid hyperplasia of uremic patients.
    Wang X, Sun B, Zhou F, Hu J, Yu X, Peng T.
    Chin Med J (Engl); 2001 Apr; 114(4):410-4. PubMed ID: 11780466
    [Abstract] [Full Text] [Related]

  • 9. Parathyroid cell growth in patients with advanced secondary hyperparathyroidism: vitamin D receptor, calcium sensing receptor, and cell cycle regulating factors.
    Tokumoto M, Taniguchi M, Matsuo D, Tsuruya K, Hirakata H, Iida M.
    Ther Apher Dial; 2005 Aug; 9 Suppl 1():S27-34. PubMed ID: 16109139
    [Abstract] [Full Text] [Related]

  • 10. 22-Oxacalcitriol upregulates p21(WAF1/Cip1) in human parathyroid glands. A preliminary report.
    Shiraishi K, Tsuchida M, Wada T, Yoshihiro S, Takai K, Suga A, Kaneda Y, Naito K.
    Am J Nephrol; 2001 Aug; 21(6):507-11. PubMed ID: 11799271
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Calcium-sensing receptor and apoptosis in parathyroid hyperplasia of patients with secondary hyperparathyroidism.
    Lee HJ, Seo UH, Kim WY, Woo SU, Lee JB.
    J Int Med Res; 2013 Feb; 41(1):97-105. PubMed ID: 23569134
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Parathyroid hyperplasia, adenomas, and carcinomas: differential expression of p27Kip1 protein.
    Erickson LA, Jin L, Wollan P, Thompson GB, van Heerden JA, Lloyd RV.
    Am J Surg Pathol; 1999 Mar; 23(3):288-95. PubMed ID: 10078919
    [Abstract] [Full Text] [Related]

  • 17. [Cell proliferation of parathyroid gland in patients with progressive secondary hyperparathyroidism: Vitamin D receptor, calcium sensing receptor, and cell cycle regulation factor].
    Tokumoto M, Taniguchi M, Matsuo D, Tsuruya K, Hirakata H, Iida M.
    Clin Calcium; 2005 Sep; 15 Suppl 1():206-16. PubMed ID: 16279026
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Analysis of proliferative activity of the parathyroid glands using proliferating cell nuclear antigen in patients with hyperparathyroidism.
    Yamaguchi S, Yachiku S, Morikawa M.
    J Clin Endocrinol Metab; 1997 Aug; 82(8):2681-8. PubMed ID: 9253354
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.